jueves, 21 de febrero de 2019

FDA warns against young-blood transfusions for aging, Alzheimer's

FDA warns against young-blood transfusions for aging, Alzheimer's

STAT

FDA: Young-blood transfusions provide ‘no proven clinical benefit’ for aging, Alzheimer’s

By REBECCA ROBBINS


ADOBE
The plasma infusions provide “no proven clinical benefit” against normal aging, Alzheimer’s disease, or a host of other diseases, the agency says.

No hay comentarios: